Autologous Blood Treatment for Ocular Surface Disease

2018-09-11 02:23:11 | BioPortfolio

Published on BioPortfolio: 2018-09-11T02:23:11-0400

Clinical Trials [2227 Associated Clinical Trials listed on BioPortfolio]

Ocular Micro-vascular Research Base on Functional Slip Lamp Biomicroscopy

Dry eye disease (DED), as one of the most common ocular surface diseases that affecting visual acuity, is highly associated with ocular surface inflammation. Until now, there is no accurat...

Outcome of Punctal Plugs on Ocular Surface Disease

Ocular surface disease is a common adverse effect of systemic isotretinoin therapy. The investigators consider that punctal plugs is simple procedure with good patient compliance for trea...

Comparison Between Rebamipide 2% Versus Autologous Serum

Two-period, controlled, randomized and open clinical trial. The sample was composed of adult women with moderate to severe hypo secretory dry eye associated with Sjögren's syndrome, who a...

Influencing Factors on Dry Eye Syndrome and Ocular Surface Disease

Dry eye syndrome and ocular surface disease are very important ophthalmologic diseases. It is known that various inducers are involved. However, it is still necessary to study how influenc...

Finger-prick Autologous Blood (FAB) for Use in Dry Mouth

This is a feasibility study that will assess the efficacy of using autologous blood to treat moderate to severe dry mouth. Dry mouth has been estimated to affect up to 64.8% of the general...

PubMed Articles [31653 Associated PubMed Articles listed on BioPortfolio]

A Review of the Cytokine IL-17 in Ocular Surface and Corneal Disease.

To investigate the role of interleukin-17 in ocular surface and corneal disease. Ocular surface and corneal disease is a leading cause of blindness and is an ongoing challenge for the public health se...

Ocular Surface Disease and Glaucoma Medications: A Clinical Approach.

Ocular surface disease frequently coexists with glaucoma and may be initiated or exacerbated by topical glaucoma medications. We performed a review of current literature to assess the prevalence, caus...

Use of Autologous Serum Tears for the Treatment of Ocular Surface Disease From Patients With Systemic Autoimmune Diseases.

Visions of Eye Commensals: The Known and the Unknown About How the Microbiome Affects Eye Disease.

Until recently, the ocular surface is thought by many to be sterile and devoid of living microbes. It is now becoming clear that this may not be the case. Recent and sophisticated PCR analyses have sh...

Review and analysis of grading scales for ocular surface staining.

Vital dye staining has been used for over a century to assess the severity of ocular surface disease. However, despite common usage, a universally accepted "gold standard" grading scale does not exist...

Medical and Biotech [MESH] Definitions

Reinfusion of blood or blood products derived from the patient's own circulation. (Dorland, 27th ed)

Ocular disorders attendant upon non-ocular disease or injury.

The functional superiority and preferential use of one eye over the other. The term is usually applied to superiority in sighting (VISUAL PERCEPTION) or motor task but not difference in VISUAL ACUITY or dysfunction of one of the eyes. Ocular dominance can be modified by visual input and NEUROTROPHIC FACTORS.

Ocular manifestations secondary to various NEOPLASMS in which antibodies to antigens of the primary tumor cross-react with ocular antigens. This autoimmune response often leads to visual loss and other ocular dysfunctions.

Recovery of blood lost from surgical procedures for reuse by the same patient in AUTOLOGOUS BLOOD TRANSFUSIONS. It is collected during (intraoperatively) or after completion of (postoperatively) the surgical procedures.

More From BioPortfolio on "Autologous Blood Treatment for Ocular Surface Disease"

Quick Search


Searches Linking to this Trial